You have 9 free searches left this month | to do more
Showing 1 - 25 of
127 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet - 2021
Completed
Has Results
  • Transfusion-dependent Thalassemia
  • Non-transfusion-dependent Thalassemia
  • Deferasirox dispersable tablet (DT)
  • Deferasirox film coated tablet (FCT)
  • Alexandria, Egypt
  • +16 more
2021-09-06
Sep 6, 2021
U
Evaluating Low-dose Deferasirox (DFX) in Patients With Low-risk MDS Resistant or Relapsing After ESA Agents
Recruiting
  • Myelodysplasia
  • Deferasirox
  • Grenoble, France
    CHU de GRENOBLE ALPES
2021-10-01
Oct 1, 2021
N
Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment - 2009
Completed
Has Results
  • Beta-thalassemia
  • Iron Overload
  • Deferasirox
  • Los Angeles, California
  • +2 more
2021-06-08
Jun 8, 2021
N
Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload - 2013
Completed
Has Results
  • Cardiac Iron Overload
  • Deferasirox and Deferoxamine
  • Toronto, Ontario, Canada
  • +14 more
2021-07-23
Jul 23, 2021
N
A Two-year Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis.
Active, not recruiting
  • Hereditary Hemochromatosis
  • Deferasirox FCT
  • Phlebotomy
  • Leuven, Belgium
  • +10 more
2021-12-03
Dec 3, 2021
E
Combined Chelation Therapy in Patients With Transfusion Dependent Thalassemia and Iron Overload - 2012
Completed
Has Results
  • Thalassemia
  • Iron Overload
  • Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO)
  • Oakland, California
    CHRCO
2021-07-20
Jul 20, 2021
D
Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation - 2021
Completed
  • Thalassemia Major
  • New York, New York
  • +3 more
2022-01-31
Jan 31, 2022
U
Risk Factors and Measures to Prevent Liver and Pancreas Complications in Pediatric Patients After HSCT
Active, not recruiting
  • Iron Overload
  • Deferasirox
  • Trieste, Italy
    IRCCS Burlo Garofolo
2022-01-04
Jan 4, 2022
N
Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients - 2008
Completed
Has Results
  • Myelodysplastic Syndromes
  • Iron Overload
  • Deferasirox
  • Stanford, California
  • +2 more
2021-06-01
Jun 1, 2021
N
Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload - 2012
Completed
  • β-thalassemia
  • Transfusional Iron Overload
  • Deferasirox
  • Cagliari, CA, Italy
  • +2 more
2020-12-06
Dec 6, 2020
N
Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox. - 2010
Completed
  • Hepatic Impairment
  • Deferasirox
  • Kiel, Germany
    Novartis Investigative Site
2020-12-06
Dec 6, 2020
U
Exjade-Early-Trial - 2013
Terminated
Has Results
  • Myelodysplastic Syndromes
  • Deferasirox (Novartis Pharma)
  • Erlangen, Bavaria, Germany
    Medizinische Klinik 5, Universitätsklinikum Erlangen
2020-09-11
Sep 11, 2020
F
Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome - 2018
Terminated
Has Results
  • Anemia
  • Myelodysplastic Syndrome
  • Deferasirox
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2020-06-12
Jun 12, 2020
U
Endocrine Function During Deferasirox Therapy - 2019
Completed
  • Iron Overload
  • +2 more
    • Naples, Italy
      Università degli Studi della Campania Luigi Vanvitelli
    2020-08-13
    Aug 13, 2020
    N
    Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload
    Active, not recruiting
    • Transfusion-dependent Anemia
    • Deferasirox granule formulation
    • Deferasirox DT formulation
    • Oakland, California
    • +36 more
    2022-01-27
    Jan 27, 2022
    N
    Safety Study of Crushed Deferasirox Film Coated Tablets in Pediatric Patients With Transfusional Hemosiderosis - 2019
    Completed
    Has Results
    • Iron Overload
    • Deferasirox
    • Zagazig, Egypt
    • +9 more
    2020-08-24
    Aug 24, 2020
    N
    Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food - 2010
    Completed
    Has Results
    • Transfusional Hemosiderosis
    • Oakland, California
    • +22 more
    2021-07-19
    Jul 19, 2021
    C
    Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients - 2017
    Completed
    Has Results
    • Chronic Iron Overload
    • Lushnjë, Albania
    • +21 more
    2021-04-08
    Apr 8, 2021
    S
    Treatment of Iron Overload Requiring Chelation Therapy
    Withdrawn
    • Transfusional Iron Overload
    • +6 more
    • (no location specified)
    2021-06-01
    Jun 1, 2021
    N
    Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation - 2019
    Completed
    Has Results
    • Chronic Iron Overload
    • Deferasirox
    • Vienna, Austria
    • +13 more
    2020-02-18
    Feb 18, 2020
    N
    Safety and Efficacy of Deferasirox in Combination With Desferoxamine in β-thalassaemia Patients With Severe Cardiac Iron Overload - 2014
    Terminated
    Has Results
    • Transfusion-dependent β-thalassemia Patients
    • Cardiac Iron Overload
    • Deferasirox
    • Deferoxamine (DFO)
    • Athens, GR, Greece
    • +3 more
    2019-10-21
    Oct 21, 2019
    N
    Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis - 2012
    Completed
    Has Results
    • Chronic Anemia
    • Transfusional Hemosiderosis
    • Deferasirox (ICL670)
    • Nagoya, Aichi, Japan
    • +30 more
    2021-06-04
    Jun 4, 2021
    N
    Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients - 2008
    Completed
    Has Results
    • Myelodysplastic Syndrome
    • Iron Overload
    • Deferasirox
    • Birmingham, Alabama
    • +47 more
    2021-07-21
    Jul 21, 2021
    N
    Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia - 2019
    Completed
    Has Results
    • Non-transfusion Dependent Thalassemia
    • deferasirox
    • Nanning, Guangxi, China
    • +10 more
    2019-09-19
    Sep 19, 2019
    B
    Pilot Study for Patients With Poor Response to Deferasirox - 2008
    Completed
    Has Results
    • Transfusion-dependent Hemachromatosis
    • +2 more
    • Boston, Massachusetts
      Children's Hospital Boston
    2019-06-14
    Jun 14, 2019